Trial intelligence / Profile preview

PROOF: Penumbral Rescue by Normobaric Oxygen Administration in Acute Ischemic Stroke

2017-001355-31Phase 2Terminated

Sponsor
University Hospital Tübingen
Start
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of oxygen in ischemic stroke (2 arms), sponsored by University Hospital Tübingen. Primary endpoint: Ischemic core growth from baseline to 24 hours. Started Jul 2018; status: terminated.

02

Drugs

oxygen
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on 2017-001355-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-001355-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call